Skip to main content
. 2019 Jun 28;13:2043–2055. doi: 10.2147/DDDT.S202818

Table 3.

The tumor inhibition rates of the treated groups (mean ± SD, n=3)

Samples Tumor inhibition rate (%)
HA-DOX/GA-LPHNs 77.7±3.2
DOX/GA-LPHNs 61.1±2.1
HA-DOX-LPHNs 51.4±2.6
HA-GA-LPHNs 34.0±1.8
Free DOX/GA 27.3±1.5